<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied the growth hormone (GH) response to GH-releasing hormone (GHRH) and the thyroid-stimulating hormone (TSH) response to thyrotropin-releasing hormone (TRH) in four groups of patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and examined whether GH and TSH secretion is altered in patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The four groups included those with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (n = 28), <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> with <z:hpo ids='HP_0000726'>dementia</z:hpo> (n = 10), <z:e sem="disease" ids="C0038868" disease_type="Disease or Syndrome" abbrv="PSNP1">progressive supranuclear palsy</z:e> with <z:hpo ids='HP_0000726'>dementia</z:hpo> (n = 10), and <z:hpo ids='HP_0000726'>dementia</z:hpo> of vascular origin (n = 28) </plain></SENT>
<SENT sid="2" pm="."><plain>The results showed no differences among the four groups in GH response to GHRH (12.2 +/- 2, 10.7 +/- 2, 8.9 +/- 1.1, and 9.9 +/- 1.9 micrograms/ml, respectively); there was no correlation between GH response to GHRH and sex, stage of the disease, or <z:hpo ids='HP_0002059'>cerebral atrophy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The proportion of patients with exaggerated, <z:mpath ids='MPATH_458'>normal</z:mpath>, or lower GH response was similar in the four groups in terms of TSH response to TRH (9.2 +/- 0.9, 11.1 +/- 1, 11.1 +/- 1, and 10.3 +/- 1 mU/ml, respectively), nor was there a correlation between TSH response to TRH and sex, stage of the disease, <z:hpo ids='HP_0002059'>cerebral atrophy</z:hpo>, or GH response to GHRH </plain></SENT>
<SENT sid="4" pm="."><plain>The proportion of those with exaggerated, <z:mpath ids='MPATH_458'>normal</z:mpath>, or lower TSH response was similar in the four groups </plain></SENT>
<SENT sid="5" pm="."><plain>Cerebrospinal somatostatin levels were similar in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> patients </plain></SENT>
<SENT sid="6" pm="."><plain>These findings indicate that neither GH response to GHRH nor TSH response to TRH provides a useful diagnostic adjunct in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> patients </plain></SENT>
</text></document>